Elemental biochemical analysis of the polysaccharides in the extracellular matrix of the yeast Saccharomyces cerevisiae by Oliveira, Fábio Luís Silva Faria et al.
Full Paper
Elemental biochemical analysis of the polysaccharides in the
extracellular matrix of the yeast Saccharomyces cerevisiae
Fábio Faria-Oliveira1, Joana Carvalho1, Celso LR Belmiro2,3, Gustavo Ramalho3, Mauro Pavão3,
Cândida Lucas1 and Célia Ferreira1
1 Centre of Molecular and Environmental Biology (CBMA), Department of Biology, University of Minho, Portugal
2 Laboratory of Glycoconjugates Biochemistry and Cellular Biology, Federal University of Rio de Janeiro,
Campus of Macaé, RJ, Brazil
3 Laboratory of Glycoconjugates Biochemistry and Cellular Biology, Institute of Medical Biochemistry, Federal
University of Rio de Janeiro, RJ, Brazil
In yeast multicellular aggregates, such as bioﬁlms and colonies, cells are supported by a yeast
extracellular matrix (yECM) of glycosidic nature, the composition of which is mostly unknown.
Saccharomyces cerevisiae ECM was produced, extracted and partitioned. An analytical-grade pure
glycoside fraction was obtained, fractionated by anionic exchange liquid chromatography and
analyzed by gas chromatography–mass spectrometry and polyacrylamide gel electrophoresis.
Two different molecular weight polysaccharides were found, composed of glucose, mannose and
small relative amounts of galactose. One of the polysaccharides had a low molecular weight,
compatible with the association with glycoproteins abundantly occurring in yECM. In addition,
these polysaccharide species were separated by diaminopropane agarose gel electrophoresis and
induced metachromatic shift, suggesting chemical substitution, which was corroborated by
anticoagulation activity. This was shown to be associated with the double deletion of the yeast
homologues of the mammalian Hedgehog modulators Hhatl and Hhat, respectively yeast Gup1
and Gup2. These results pioneer the study of the molecular biology of the ECM supporting S.
cerevisiae multicellular aggregates such as bioﬁlms.
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Introduction
In a multicellular organism, the maintenance of the
homeostatic balance required for regular function
ultimately depends on the extracellular matrix (ECM)
where cells are embedded. The ECM provides a cell-
supportingscaffoldandhelpsmaintainingthebiophysical
integrity of tissues and organs. ECM is under constant
remodeling, changing rigidity, porosity and spatial
disposition, therefore orienting cell movement and tissue
growing [1, 2]. Moreover, the diffusion of molecules from
cell to cell depends on ECM, that in this way inﬂuences
directly the availability of signalling effectors of all kinds,
including growth factors and hormones [3, 4], playing
crucial roles in all tissue rearrangements [5].
Mammalian ECM presents a great number of func-
tional molecules, biochemically and biophysically
diverse, including proteins, glycoproteins, glycosamino-
glycans (GAGs) and proteoglycans (PGs). PGs are vital
structural and signalling molecules composed of a core
protein with one ormore covalently attached GAGs [6, 7],
which can be a single GAG, as decorin [8], or several units
of different GAGs, as versican and aggrecan [9, 10]. GAGs
are linear heteropolysaccharides consisting of repeating
disaccharide units, composed of a hexosamine (glucos-
amine or galactosamine, frequently N-substituted) and a
hexuronic acid (glucuronic acid or iduronic acid).
Exceptionally, in keratan sulphate, N-acetyl-glucosamine
associates with galactose instead. GAGs are generally
multi-sulphated, with the exception of hyaluronan [6, 7,
11–13]. In mammals, a few PGs are secreted to the
Correspondence: Cândida Lucas, CBMA, Department of Biology,
University of Minho, Campus de Gualtar, 4710-054 Braga, Portugal
E-mail: clucas@bio.uminho.pt
Phone: þ351253604310
Fax: þ351253678980
Environment  Health  Techniques
Saccharomyces cerevisiae extracellular matrix polysaccharides 685
 2015 WILEY-VCH Verlag GmbH & Co.KGaA,Weinheim www.jbm-journal.com J. Basic Microbiol. 2015, 55, 685–694
extracellular space, like the large molecular weight
aggrecan, or the small leucine-rich PGs [14–16]. Some are
membrane tethered, through a glycosylphosphatidyli-
nositol anchor, like glypican, or by a membrane
spanning protein core, as syndecan [7, 17]. A high
molecular diversity arises from the different combina-
tions of PGs protein cores with one or more types of
GAGs, eventually leading to a wide variety of biological
roles. As such, disturbances in PGs synthesis and
turnover lead to severe pathologies [5]. Moreover,
important medical properties were also reported for
some ECM components. Heparin, for example, presents
anti-thrombotic, anti-coagulant, anti-inﬂammatory and
anti-metastatic properties [18–20].
The presence of ECM-like extracellular polymeric
substances is known to support and protect multi-
cellular bacterial and fungal aggregates [21–27]. Cells of
the yeast Saccharomyces cerevisiae are able to form
numerous multicellular aggregates: colonies [28],
stalks [29, 30] andmats/bioﬁlms [31, 32]. Colonies display
complex organization, being cells embedded in an ECM-
like extracellular polymeric substance with glycosidic
nature [27, 33]. This substance promotes the conduction
of nutrients and water to the top layers of cells in the
colony [27], preventing desiccation [34] and providing
protection against xenobiotics [33]. A colony contains
subpopulations of cells in different physiological
states [35], a substantial part of which in a non-
dividing/quiescent state [36]. In accordance with diverse
physiological states, differently positioned cells in a
colony express different genes [37–39]. Identically, the
bioﬁlms formed by the opportunistic human pathogen
Candida albicans also present multicellular spatial
organization, supported by an extracellular matrix in
which genetically different cells are embedded [40–43].
The chemical nature ofmicrobial ECMhas been poorly
assessed [40–42]. In bioﬁlms of C. albicans, ECM was
shown to contain proteins, polysaccharides and DNA [42,
44, 45]. In colonies of S. cerevisiae, ECMwas shown to also
contain proteins—glycoproteins—and to be highly
glycosylated [27, 33]. In ﬂocs produced during fermen-
tation of S. cerevisiae strains overexpressing the ﬂocculin
gene FLO1, ECM was reported to contain mono- and
polysaccharides of glucose and mannose, the latter in
the form of highly branched mannan [46]. The lack of
detailed biochemical and structural information on the
sugar scaffold of yeast ECM, be it in colonies, ﬂocs or
bioﬁlms, derives from the difﬁculty in producing
amounts large enough to apply heavy chromatographic
procedures. This problem has been overcome applying a
new methodology for mimicking bioﬁlms through the
production of homogenous mats of cells from which
large amounts of yeast ECM can be easily extracted,
allowing straightforwardmanipulation of strains, media
and growth conditions [47]. In the present work,
abundant ECM from bioﬁlm-like mats of S. cerevisiae
was extracted and partitioned to obtain an analytical-
grade glycoside fraction. This was analyzed by mass
spectrometry, anion exchange liquid chromatography,
polyacrylamide gel electrophoresis and diaminopropane
agarose gel electrophoresis. Two polysaccharide species
were identiﬁed, which were composed of glucose,
mannose, galactose and putatively uronic acid. In
addition, chemical substitution was evidenced by (1)
induced metachromasia in toluidine blue and dimethy-
methylene blue dyes and (2) the degree of the activated
partial thromboplastin time observed in samples that
originated from different yeast strains. Although the
chemical nature of the glycoside bonds and the macro-
molecular structure of the polysaccharides require other
in-depth analytical approaches, this work pioneers the
acknowledgement of the polysaccharide nature and
complexity of S. cerevisiae ECM.
Materials and methods
Strains, media and culture conditions
The S. cerevisiae strains W303–1A (MATa leu2–3 leu2–112
ura3–1 trp1–1 his3–11 his3–15 ade2–1 can1–100), BHY54,
Cly5andCly3 (isogenic toW303–1Abutgup1::His5þ,gup2::
KanMX or gup1::His5+gup2::KanMX, respectively) [48] were
used. Batch cultures were performed in YPD (Himedia,
India) [1%yeastextract (w/v), 2%peptone (w/v), 2%glucose
(w/v), 0.005% adenine hemisulphate (w/v)] at 200 rpm,
30 °C and the air to liquid ratio of 2:1. Growth was
monitoredbymeasuringOD600. Soluble yeast ECM (yECM)
from bioﬁlm-like mat was prepared as described
before [47].
yECM protein fraction collection and western blotting
The yECM protein fraction was obtained supplementing
the culture homogenisation buffer [47] with a protease
inhibitor cocktail (PMSF, 0.2mgml1, Aprotinin, 0.32mg
ml1, Pepstatin, 1mgml1, Leupeptin, 1mgml1). All
enzymes were purchased from Sigma (EUA). The
suspension was centrifuged (10min, 15,000 rpm, 4 °C)
(Sigma 4–16K). The supernatant was ﬁltered through a
0.45-mm membrane and freeze-dried (Christ Alpha 2–4
Christ LDC-1m, B. Braun). Proteins were separated in
10%PAGE, blotted in a PVDFmembrane (BioRad, DE) and
probed with concanavalin A-HRP (Horse Radish Perox-
idase) conjugate (Sigma, EUA), as previously
described [27].
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yECM glycoside fraction collection, polysaccharide
precipitation and separation
Freeze dried yECM [47] was resuspended in digesting
buffer (0.1M sodium acetate (Merck, DE), 5mM EDTA
(Sigma, EUA), 5mM cysteine (Merck, DE), pH 5.5) at 1 g
20ml1. Double-crystalized papain (Sigma, EUA) was
added to the mixture (10mgml1) and incubated at
60 °C overnight to degrade proteins in suspension. The
mixture was centrifuged (3000 rpm, 10min, 4 °C) (Sigma
4–16K), and the clear supernatant was collected and
subjected to ethanol precipitation. Three volumes of
ethanol (Sigma, EUA) 95–99% (v/v) were added to the
supernatant and incubated overnight at 4 °C. The
precipitate was collected by centrifuging (3000 rpm,
10min, 4 °C) and left to evaporate the residual ethanol.
An aliquot of the resulting pellet was resuspended in
deionized water, stored at 4 °C and used for (1) electro-
phoretic analysis, (2) evaluation of total sugar using the
phenol–sulphuric acid method [49], (3) probing the
presence of hexuronic acids by the carbazole method [50]
and (4) testing metachromatic shift of 1,9-dimethyl-
methylene blue (DMMB) [51, 52]. Another aliquot of the
ethanol-precipitated pellet (20mg) was resuspended in
1ml of MilliQ water, ﬁltered through a 0.22-mm syringe
ﬁlterandappliedtoaHitrapQ-XL-FPLCcolumnforanionic
exchange liquid chromatography (FPLC) (Pharmacia
Biotech). The column was equilibrated with 20mM Tris-
HCl (Merck, DE) (pH 8.6). The polysaccharides were eluted
bya lineargradientof0–3.0MNaCl (Merck,DE) (10ml) at a
ﬂow rate of 0.50mlmin1, fractions of 0.5ml were
collected. Hexuronic acids [50], total sugars [49] and
sulphated polysaccharides were assessed [52]. The frac-
tions with detected peaks were collected, dialysed against
MilliQ water for 48h and freeze-dried.
Chemical analysis of yECM glycoside fraction
Gas chromatography–mass dpectrometry (GC–MS). The
monosaccharide ratio was determined by GC–MS,
analyzing the corresponding alditol acetate derivatives,
as previously described [53]. Brieﬂy, the samples were
fast hydrolysed with triﬂuoroacetic acid (Fisher, EUA) at
100 °C for 4h. The monosaccharides released were
converted into alditol acetate derivatives by successive
reduction with NaBH4 (Fisher, EUA) and acetylation with
Ac2O pyridine (Merck, DE), allowing identiﬁcation by
GC–MS. The samples were analyzed by a GC–MS system
(Shimadzu QP2010 Plus) equipped with a Restek RTX-
5MS column. Ultrapure helium (99.999%) was used as
the carrier at a constant ﬂow rate of 1.0mlmin1. The
oven temperature was programmed to increase from 110
to 260 °C in a 70-min period. The ion source and interface
temperatures were 200 and 230 °C, respectively.
Glycosaminoglycan–polyacrylamide gel electrophoresis
(GAG–PAGE). Each sample (10mg) of yECM glycosides
was applied to a 1-mm-thick 6% polyacrylamide (BioRad,
DE) gel in 3X polyacrylamide gel electrophoresis (PAGE)
running buffer (60mM Tris-HCl, pH 8.6). Electrophoresis
was run at 100V. The gel was stainedwith 0.1% toluidine
blue (Merck, DE) in 1% acetic acid (Sigma, EUA). After
staining, the gel was washed overnight in 1% acetic acid.
The markers of molecular mass (Sigma, EUA) were
dextran sulphate 8 (average MW: 8000 Da), chondroitin
4-sulphate (average MW: 36,000 Da) and dextran
sulphate 100 (average MW: 100,000 Da).
Diaminopropane agarose gel electrophoresis (DAE). Dia-
minopropane agarose gel electrophoresis (DAE) was
performed as described previously [13]. Brieﬂy, app.
1.5mg of the sample was applied to a 0.5% agarose
(Sigma, EUA) gel in a buffer composed of 50mM 1,3-
diaminopropane acetate (Sigma, EUA) (pH 9.0), and
electrophoresis was run for 1h at 100V. As a standard, a
mixture of glycosaminoglycans (GAGs) (Sigma, EUA),
containing chondroitin sulphate (CS), dermatan sul-
phate (DS) and heparan sulphate (HS) (1.5mg of each),
was used. GAGswereﬁxedwith aqueous 0.1%Cetavlon1
(Sigma, EUA), air dried and stained with 0.1% toluidine
blue in acetic acid/ethanol/water (0.1:5:5, v/v/v).
Anticoagulant effect measured by activated partial
thromboplastin time (aPTT). Assays of activated partial
thromboplastin time (aPTT) were performed by incubat-
ing 100ml of human plasma with 10ml of the yECM
polysaccharide sample at 37 °C for 1min. As a control,
incubation was performed with a solution standard of
porcine intestinal mucosa heparin (50mgml1) (Sigma,
EUA). Subsequently, 100ml of cephalin (Fisher, EUA)were
added, and the mixtures were re-incubated for 2min,
after which 100ml of CaCl2 (Sigma, EUA) (0.25M) were
added and the clotting time recorded in a coagulometer
(KC4A, Amelung) [54]. The experiments using human
blood samples were performed in accordance with the
Declaration of Helsinki (2008) of the World Medical
Association and were approved by the Ethics Committee
of the Federal University of Rio de Janeiro, Brazil.
Results
S. cerevisiae ECM glycoside composition
A well-known laboratory wild-type strain of S. cerevisiae
(W303) was used to produce and extract yECM and purify
the correspondent glycoside fraction. The approach
yielded an analytical-grade pure fraction that was used
to identify the components of yECM polysaccharides.
GC–MS results (Fig. 1) indicated the presence of glucose
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(52%), mannose (44%) and galactose (4%). Furthermore,
considering that polysaccharides containing uronic
acids, common in ECM of higher eukaryotes [7], have
also been reported in bacterial ECM [24, 55], the presence
of uronic acidswasﬁrstly tested by the carbazolemethod
using the yECM sample before separation of protein/
sugar fractions. Results were positive for the presence of
this type of sugar (not shown).
The yECM glycoside sample was subsequently ana-
lyzed by GAG–PAGE. Two different polydisperse bands
were observed (Fig. 2A, arrows). The polydispersion
obtained during the electrophoretic migration of poly-
saccharides derives from the possible existence of
different numbers of repeating saccharide units in a
same glycoside species. Their average size of app.
35–40kDa and <8kDa was estimated by comparison
Figure 1. Mass spectrometry of S. cerevisiae ECM glycoside fraction. GC–MS of yECM glycoside constituents showed the presence of
glucose, mannose and galactose. The retention times and main mass-to-charge ratios for each monomer are included in the table.
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with the known molecular weight (MW) of the GAGs in
control lanes. The higher MW band (app. 35–40kDa) was
present in much lesser amounts than the lower MW
band (<8kDa). This last band could consist of oligosac-
charides and/or disaccharide units, likely associatedwith
glycoproteins in yECM. The putative existence of this
type of proteins was probed in the yECM sample prior to
glycoside/protein fractionation using concanavalin A,
which recognizes glycosyl andmannosyl groups. Intense
bands were detected, most of which were easily
attributable to protein bands on the correspondent
SDS–PAGE (Fig. 2B). These results concur with previous
suggestions from the literature in which S. cerevisiae ECM
contains glycoproteins and displays a highly glycosy-
lated pattern [27, 33] further showing the correspondent
sugar composition.
Putative chemical substitution of extracellular matrix
(ECM) polysaccharides in S. cerevisiae
The inductionofmetachromasia is frequent inchemically
substituted polysaccharides, namely highly sulphated
GAGs from ECM of higher eukaryotes [56]. A ﬁrst assay
using the yECM polysaccharide extract induced meta-
chromasia in DMMB and toluidine blue dyes (not shown).
Subsequently, the yECM glycoside sample was fractioned
by FPLC (Fig. 3A). Fractions (0.5ml) were collected, and
each one was tested for metachromasia and uronic acids.
As a control, total sugars in each fractionwere quantiﬁed.
According to the above-mentioned results from GAG–
PAGE, fractionation of yECM yielded two major sugar
peaks (P1andP2) (Fig.3A).Both inducedmetachromasia in
DMMB (Fig. 3A). In addition, P1 and P2were also tested for
uronic acids and yielded positive results (Fig. 3A),
consistent with the above-mentioned results using the
unfractionated yECM sample.
The P1 and P2 fractions were further analyzed by DAE
(Fig. 3B). DAE is a powerful tool to separate compounds
with different degrees of chemical substitution, usually
sulphated polysaccharides [57]. As a control, the unfrac-
tionated yECM sample—PC (pre-chromatographic) frac-
tion—was used. This sample presented two polydisperse
Figure 2. Electrophoretic analysis of S. cerevisiae ECM polysac-
charides (A) and proteins (B). (A) GAG–PAGE of the yECM glycoside
fraction revealed two components (arrows), one with 8 kDa and
another in considerably smaller amounts with app. 35–40kDa.
Molecular weight standards (STD): DexS100, dextran sulphate (MW:
100,000 Da), CS4, chondroitin 4-sulphate (MW: 36,000 Da) and
DexS8, dextran sulphate (MW: 8000 Da). (B) SDS–PAGE analysis of
theyECMprotein fraction.andfurtherblottingwithconcanavalinA-HRP
(Horse Radish Peroxidase) conjugate for the presence of glycopro-
teins. (CCB, Colloidal Coomassie Blue staining).
Figure 3. Chromatographic fractionation and electrophoretic proﬁles of S. cerevisiae ECM polysaccharides. (A) FPLC of the yECM glycoside
fraction yielded twomain compounds, P1 and P2. (B) DAE of P1 and P2 was compared with that of the sample prior to FPLC fractionation (PC).
GAG standards (STD): CS, chondroitin sulphate; DS, dermatan sulphate; HS, heparan sulphate.
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bands of twometachromatic compounds thatmigrated in
amanner similar to CS and HS. Each corresponded to one
of theP1 andP2 fractions (Fig. 3B). Similar to other reports
usingbothFPLCfractionationandDAE[56], theﬁrsteluted
ECM component (P1) matched the shortest migration in
DAE. Combining these results with the results in Fig. 2A,
these two compounds are likely to be differentmolecules.
S. cerevisiae extracellular matrix (ECM)
polysaccharides display anticoagulant activity
Several studies showed the importance of sulphate
substitution for the anticoagulant effect of heparin [58],
DS [59] or their analogues [13, 18, 54]. In the literature
concerning yeast, there is no reference to polysaccharide
sulphation processes. Therefore, yECM components
were further assessed for anticoagulant properties as a
means to conﬁrm the existence of this type of chemical
substitution in yeast. The yECM PC fraction (above) was
tested in vitro for anticoagulant properties by measuring
aPTT [54]. For this assay, the S. cerevisiae wild type strain
was used in parallel with the mutants defective in GUP1
and/or GUP2, the genes encoding the yeast counterparts
of the mammalian Hedgehog pathway modulators,
HHATL and HHAT [60]. In mammals, ECM is the major
vehicle and modulator of Hedgehog signalling, to which
it responds with ever changing molecular structure and
composition [3, 4]. The PC fractions from the S. cerevisiae
wild type strain, the single deletion strains, gup1D and
gup2D and the double deletion strain, gup1Dgup2Dwere
used to test the anticoagulant effect. Heparinwas used as
a control. Results in Fig. 4 show that yECM from the wild
type strain and gup1D and gup2D strains did not display
a detectable anticoagulant effect, while in contrast, the
yECM extract from the gup1Dgup2D mutant strain
displayed a signiﬁcant effect.
Discussion
The present studywas devised to determine the chemical
composition of the glycoside components in ECM of S.
cerevisiae bioﬁlms. To achieve this and considering that S.
cerevisiae does not form bioﬁlms on inert surfaces as
easily as other well-known yeasts such as C. albicans or C.
glabrata [31], we devised a method to produce large
bioﬁlm-like homogenous overlays of cells mats from
which generous amounts of ECM could be reproducibly
extracted fuelling chemical/molecular analysis [47].
Previous results for ECM of C. albicans bioﬁlms
revealed the presence of b-1,3 glucan and a polysac-
charide composed of a-D- and b-D-glucose, a-D-mannose,
a-L-rhamnose andN-acetylglucosamine [25]. On the other
hand, in S. cerevisiae ECM, the presence of glycoproteins
was reported for colonies [27, 33]. Flocs from S. cerevisiae
overexpressing FLO1 secreted glucose and mannose,
most of which organized into highly branched poly-
saccharides [46]. These authors also reported the
presence of galactose, but attributed it to plasmid
induction requests used during cells culture. Our results
using a wild type strain of S. cerevisiae cultivated to form
bioﬁlm-like mats showed the yECM glycoside fraction to
be composed of glucose, mannose and galactose. The
relative amounts of galactose predicted by this method-
ology are very small, therefore, its true existence
Figure 4. Anticoagulant effect of S. cerevisiae ECM extracts from several yeast strains. The anticoagulant effect of yECM polysaccharides
originating from wild type and mutant yeast strains was tested measuring the activated partial thromboplastin time (aPTT) assay. Differences in
the anticoagulant effect represent an indirect measurement of the presence of sulphate groups. Porcine intestinal mucosa heparin (50mgml1)
was used as a control. UA stands for uronic acid.
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requires further conﬁrmation. Still, ﬁlamentous fungi
have been reported to produce galactoglycans, such as
the galactomannan found in Aspergillus fumigatus
bioﬁlms [61] or the galactoxylomannan found in the
capsule of the yeast Cryptococcus neoformans [62]. On the
other hand, chemical staining revealed the putative
presence of uronic acids, which were undetected by
GC–MS. Although the presence of uronic acids has been
reported in other microbes [24, 55], this requires
conﬁrmation by in-depth analytical methods.
GAG–PAGE of the yECM glycoside fraction showed the
presence of two glycoside species with different MW,
whichwere subsequently separatedbyFPLC.Theonewith
the lower MW (<8kDa), consistent with the highly
glycosylated nature of the SDS–PAGE proﬁle as revealed
by the association with concanavalin A, could comprise
oligosaccharides and/or disaccharide units belonging to
glycoproteins in vivo. Bothglycoside species testedpositive
for uronic acids by chemical staining. In addition, they
also tested positive for chemical substitution by meta-
chromasia, which was conﬁrmed in the unfractionated
yECM sample composed of sugars and proteins and by
DAE. The induction of metachromasia is frequent in
chemically substituted polysaccharides, namely highly
sulphatedGAGs fromECMof higher eukaryotes [56] and is
mostly associated with the presence of sulphate
groups [52].However,metachromasiamayalsobe induced
by a wide variety of polyanions [51, 63, 64], such as
polyphosphates, polyacrylates, polysulphates, carboxy-
lated polysaccharides and some proteins and nucleic
acids [51]. The methodologies used to separate yECM
proteinandglycoside fractions ensure aglycosideprotein-
free fraction but do not avoid putative very low mass
contaminants such as amino acids or nucleotides. Never-
theless, the clearness of the DAE electrophoretic proﬁle
strongly suggests the absence of these contaminants, or
their putative presence in amounts below the level of
detection.
The sulphation pattern is considered to be responsible
for the degree of anticoagulation ability of mammalian
heparin and other polysaccharides [18]. Considering the
absence of references in the literature to polysaccharide
sulphation in yeast, the results obtained with meta-
chromasia and DAE were challenged through an assay of
anticoagulation activity against human plasma—aPTT.
For this purpose, several yeast genetic backgrounds were
used. The rationale behind their choice is the fact that
mammalian ECM governs and is governed by the
Hedgehog signalling pathway [3, 4], for which Hhat
and Hhatl modulators [60] were ﬁrst described as yeast
proteins, Gup1p and Gup2p [65, 66]. Gup1p and Gup2p
are extremely pleiotropic, interfering with namely cell
wall and plasma membrane composition and function,
including wall polysaccharide assembly, lipid metabo-
lism and rafts and GPI anchors integrity [48, 67, 68]. The
anticoagulation activity displayed by the gup1Dgup2D
mutant suggests that the disruption of these genes
triggers a process of chemical substitution of yECM
polysaccharides absent or residual in the other strains,
including the wild type strain. As mentioned above,
there is no evidence in yeast of a molecular apparatus
that may be responsible for sulphation of polysacchar-
ides or other compounds. Anticoagulation activity
suggests that sulphate substitution may actually be
possible in yeast. Ultimately, the differences observed
between mutant strains defective in either or both GUP
genes also suggest that it is dynamically regulated, in
which the two Gup proteins may have a role.
Final remarks
This work reports the chemical nature of S. cerevisiae
ECM polysaccharides. Indications are provided of the
presence of two differentMWpolysaccharides composed
of glucose, mannose and galactose and putatively also
uronic acids. Moreover, results also point to chemical
substitution of yECM polysaccharides, compatible with
the results obtained with metachromasia by DMMB and
toluidine blue, DAE and aPTT. The fact that the observed
yECM-derived anticoagulant effect was restricted to
yECM from a mutant lacking both yeast Gup1 and Gup2
proteins suggests the involvement of both proteins in the
process of chemical modiﬁcation of yECM polysacchar-
ides. The fact that this effect was not detected in the wild
type strain and in the correspondent single mutant
further suggests dynamic regulation of the underlying
processes, which may be absent or simply below
detection levels in these strains. Finally, considering
that sulphation governs anticoagulation properties of
mammalian, algae and ascidian polysaccharides, results
suggest an equivalent nature of chemical substitution of
yECMpolysaccharides. These results pioneer the study of
yeast cell surface glycomics beyond the cell wall in the
context of bioﬁlms or colonies as multicellular aggre-
gates, opening the way to a new understanding of yeast
in a societal context of large multicellular aggregates,
analogous to higher eukaryotic tissues.
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